The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
The genetics and immunopathogenesis of inflammatory bowel disease
Abstract
Genome-wide association studies efficiently and powerfully assay common genetic variation. The application of these studies to Crohn's disease has provided insight into the immunopathogenesis of this disease, implicating a role for genes of the innate and adaptive immune systems. In this Review, I discuss our current understanding of the genetics and immunopathogenesis of Crohn's disease and ulcerative colitis. Crohn's disease, but not ulcerative colitis, is associated with genetic variation in NOD2 and an autophagy gene, ATG16L1, both of which affect the intracellular processing of bacterial components. By contrast, variation in the gene encoding the interleukin-23 (IL-23) receptor subunit, as well as in the IL12B, STAT3 and NKX2-3 gene regions, is associated with both Crohn's disease and ulcerative colitis. Comparative analyses of gene associations between these two inflammatory bowel diseases reveal common and unique mechanisms of their immunopathogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the expansion of Proteobacteria could facilitate a mucosal immune response in genetically predisposed individuals, leading to the development and continuation of chronic intestinal inflammation[133,142,143].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [143]
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Self-citationA second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Loftus, E. V. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.063 · Cited by 3,106
Flagged first, then by citations
Research works printed but not linked: 2
- Binder, V. Genetic epidemiology in inflammatory bowel disease. Digest. Dis. 16, 351–355 (1998). · DOI
- Yang, H. & Rotter, J. I. in Inflammatory Bowel Disease (eds Kirsner, J. B. & Shorter, R. G.) 301–331 (Williams & Wilkins, Baltimore, 1995).
Cited by
Sorted by citations
Items 401–500 of 939
Marks, B. R., & Craft, J. E. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.03.001 · Cited by 33
Human genetics offers an emerging picture of common pathways and mechanisms in autoimmunity
Voight, B. F., & Cotsapas, C. J. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.013 · Cited by 33
Functional Analyses of the Crohn’s Disease Risk Gene LACC1
Assadi, G., Vesterlund, L., Bonfiglio, F., Mazzurana, L., Cordeddu, L., Schepis, D., Mjösberg, J., Ruhrmann, S., Fabbri, A., Vukojević, V. B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168276 · Cited by 33
Park, S., Kim, T. J., Lee, J., Kim, E. R., Hong, S. N., Chang, D. K., Yang, M. R., Kim, S., Shin, M., & Kim, Y. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15076 · Cited by 33
Repnik, K., & Potočnik, U. (2010) · DNA and Cell Biology · doi:10.1089/dna.2010.1021 · Cited by 32
Protein kinase 2 (CK2) controls CD4+ T cell effector function in the pathogenesis of colitis
Yang, W., Gibson, S. A., Yan, Z., Wei, H., Tao, J., Sha, B., Qin, H., & Benveniste, E. N. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0258-x · Cited by 35
Blockade of CXCR2 suppresses proinflammatory activities of neutrophils in ulcerative colitis.
Zhu, F., He, H., Fan, L., Ma, C., Xu, Z., Xue, Y., Wang, Y., Zhang, C., & Zhou, G. (2020) · PubMed Central · Cited by 32
IL-1 receptor-associated kinase M downregulates DSS-induced colitis†
Berglund, M., Melgar, S., Kobayashi, K. S., Flavell, R. A., Hörnquist, E. H., & Hultgren, O. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21287 · Cited by 32
Kapadia, B. H., Issa, K., Nagrare, N., Pivec, R., Banerjee, S., & Mont, M. A. (2013) · The Journal of Arthroplasty · doi:10.1016/j.arth.2013.07.011 · Cited by 32
Therapeutic potential of chloroquine in a murine model of inflammatory bowel disease
Nagar, J., Ranade, S., Kamath, V., Singh, S., Karunanithi, P., Subramani, S., Venkatesh, K., Srivastava, R., Dudhgaonkar, S. P., & Vikramadithyan, R. K. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.05.005 · Cited by 32
Algaba, A., Linares, P. M., Fernández-Contreras, M. E., Ordóñez, A. F., Trápaga, J., Guerra, I., Chaparro, M., de la Poza, G., Gisbert, J. P., & Bermejo, F. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.04.005 · Cited by 32
Ermann, J., Garrett, W. S., Kuchroo, J. R., Rourida, K., Glickman, J. N., Bleich, A., & Glimcher, L. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104234108 · Cited by 32
Sun, S., Wang, X., Wu, X., Zhao, Y. L., Wang, F., Liu, X., Song, Y., Wu, Z., & Liu, M. (2011) · Parasites & Vectors · doi:10.1186/1756-3305-4-186 · Cited by 32
Dige, A. K., Magnusson, M. K., Öhman, L., Hvas, C. L., Kelsen, J., Wick, M. J., & Agnholt, J. S. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1134649 · Cited by 32
Dudarewicz, M., Barańska, M., Rychlik‐Sych, M., Trzciński, R., Dziki, A. J., & Skrętkowicz, J. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70774-0 · Cited by 31
Forte, D., Ciciarello, M., Valerii, M. C., Fazio, L. D., Cavazza, E., Giordano, R., Parazzi, V., Lazzari, L., Laureti, S., Rizzello, F., et al. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0166-2 · Cited by 31
Microbiota biodiversity in inflammatory bowel disease
Comito, D., Cascio, A., & Romano, C. (2014) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-40-32 · Cited by 31
Effect of Trichinella spiralis intervention on TNBS-induced experimental colitis in mice
Xu, J., Yu, P., Wu, L., Liu, M., & Lu, Y. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.09.005 · Cited by 31
Wang, L., Ji, T., Yuan, Y., Fu, H., Wang, Y., Tian, S., Hu, J., Wang, L., & Wang, Z. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108814 · Cited by 31
Bar‐On, L., Zigmond, E., & Jung, S. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.002 · Cited by 31
Cytokine IL9 Triggers the Pathogenesis of Inflammatory Bowel Disease Through the miR21-CLDN8 Pathway
Li, L., Huang, S., Wang, H., Chao, K., Ding, L., Feng, R., Qiu, Y., Feng, T., Zhou, G., Hu, J., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy187 · Cited by 31
Genetic profile of patients with early onset inflammatory bowel disease
Girardelli, M., Basaldella, F., Paolera, S. D., Vuch, J., Tommasini, A., Martelossi, S., Crovella, S., & Bianco, A. M. (2017) · Gene · doi:10.1016/j.gene.2017.12.029 · Cited by 32
Arranz, A., Reinsch, C., Papadakis, K. A., Dieckmann, A., Rauchhaus, U., Androulidaki, A., Zacharioudaki, V., Margioris, A. N., Tsatsanis, C., & Panzner, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.008 · Cited by 30
Hirschsprung-associated enterocolitis develops independently of NOD2 variants
Lacher, M., Fitze, G., Helmbrecht, J., Schroepf, S., Berger, M., Lohse, P., Koletzko, S., Ballauff, A., Grote, V., Goedeke, J., et al. (2010) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2010.02.039 · Cited by 30
Yu, W., Hegarty, J. P., Berg, A. S., Chen, X., West, G. A., Kelly, A. A., Wang, Y., Poritz, L. S., Koltun, W. A., & Lin, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020454 · Cited by 30
Barrie, A. M., Khare, A., Henkel, M., Zhang, Y., Barmada, M. M., Duerr, R. H., & Ray, A. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00300.x · Cited by 30
Mind–Body Interventions for Pediatric Inflammatory Bowel Disease
Yeh, A. M., Wren, A. A., & Golianu, B. J. (2017) · Children · doi:10.3390/children4040022 · Cited by 33
The socio-economic impact of work disability due to inflammatory bowel disease in Brazil
Fróes, R. D. S. B., Carvalho, A. T. P., Carneiro, A. J., Moreira, A. M. H. D. B., Moreira, J. P. D. L., Luiz, R. R., & de Souza, H. S. P. (2017) · The European Journal of Health Economics · doi:10.1007/s10198-017-0896-4 · Cited by 30
Li, Z., Ma, T., Zhang, W. Y., Shang, Y., Zhang, Y., & Ma, Y. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00639-9 · Cited by 30
OCTN1 variant L503F is associated with familial and sporadic inflammatory bowel disease
Lin, Z., Nelson, L. S., Franke, A., Poritz, L. S., Li, T.-Y., Wu, R., Wang, Y., MacNeill, C., Thomas, N. J., Schreiber, S., et al. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.09.003 · Cited by 29
Troncone, E., Marafini, I., Blanco, G. D. V., Grazia, A. D., & Monteleone, G. (2020) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s208020 · Cited by 29
Helbig, K. L., Nothnagel, M., Hampe, J., Balschun, T. C., Nikolaus, S., Schreiber, S., Franke, A., & Nöthlings, U. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-14 · Cited by 29
Assi, K., Patterson, S., Dedhar, S., Owen, D. A., Levings, M. K., & Salh, B. S. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-42 · Cited by 29
DNA-driven nutritional therapy of inflammatory bowel disease
Lee, G., & Buchman, A. L. (2009) · Nutrition · doi:10.1016/j.nut.2009.06.011 · Cited by 29
Rigoni, A., Bongiovanni, L., Burocchi, A., Sangaletti, S., Danelli, L., Guarnotta, C., Lewis, A., Rizzo, A. G., Silver, A. R., Tripodo, C., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3767 · Cited by 29
Hong, J. Y., Chung, K., Shin, J., Park, G., Jang, Y. P., & Lee, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010177 · Cited by 29
Immunopathogenèse des maladies inflammatoires chroniques de l’intestin
Matricon, J. (2010) · médecine/sciences · doi:10.1051/medsci/2010264405 · Cited by 29
Pharmacogenomics of multiple sclerosis: in search for a personalized therapy
Martínez‐Forero, I., Peláez, A., & Villoslada, P. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802515553 · Cited by 29
Bitencourt, M. A. O., Silva, H. M. D., Abílio, G. M. F., de Miranda, G. E. C., de Moura, A. M. A., de Araújo‐Júnior, J. X., da Silveira, É. J. D., Santos, B. V. D. O., & de Souto, J. T. (2015) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2015.10.001 · Cited by 28
Ergin, A., Syrbe, U., Scheer, R., Thiel, A., Adam, T., Büssow, K., Duchmann, R., Zeitz, M., & Sieper, J. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9575-x · Cited by 28
Yu, P., Shen, F.-C., Zhang, X., Cao, R., Zhao, X., Liu, P., Tu, H., Yang, X., Shi, R., & Zhang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044380 · Cited by 28
ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses
Honjo, H., Watanabe, T., Arai, Y., Kamata, K., Minaga, K., Komeda, Y., Yamashita, K., & Kudo, M. (2020) · International Immunology · doi:10.1093/intimm/dxaa062 · Cited by 28
Zhang, Y., Li, X., Li, Y., Li, Y., Wang, Y., Zhu, L., Chen, P., Tian, Z., Qiu, Y., Feng, R., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06697-2 · Cited by 28
Loh, J. T., Lee, K.-G., Lee, A., Teo, J. K. H., Lim, H. L., Kim, S. S.-Y., Tan, A. H., & Lam, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04357-5 · Cited by 28
Mondal, S., Das, M., Ghosh, R., Singh, M., Adhikari, A., Darbar, S., Das, A. K., Bhattacharya, S. S., Pal, D., Bhattacharyya, D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05023-6 · Cited by 28
Animal Models of Inflammatory Bowel Disease at the Dawn of the New Genetics Era
Sollid, L. M., & Johansen, F. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050198 · Cited by 29
Rahman, F. Z., Smith, A. M., Hayee, B., Marks, D. J., Bloom, S. L., & Segal, A. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009891 · Cited by 28
Lawrenz, M. B., Visekruna, A., Kühl, A. A., Schmidt, N., Kaufmann, S. H. E., & Steinhoff, U. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.57 · Cited by 30
Conway, T. F., Hammer, L. A., Furtado, S., Mathiowitz, E., Nicoletti, F., Mangano, K., Egilmez, N. K., & Auci, D. L. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv089 · Cited by 28
MAG-EPA reduces severity of DSS-induced colitis in rats
Morin, C., Blier, P. U., & Fortin, S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00136.2015 · Cited by 28
Adamik, J., Henkel, M., Ray, A., Auron, P. E., Duerr, R. H., & Barrie, A. M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.010 · Cited by 27
Hosomi, S., Watanabe, K., Nishida, Y., Yamagami, H., Yukawa, T., Otani, K., Nagami, Y., Tanaka, F., Taira, K., Kamata, N., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy005 · Cited by 27
Henry, C., Bassignani, A., Berland, M., Langella, O., Sokol, H., & Juste, C. (2022) · Cells · doi:10.3390/cells11081340 · Cited by 28
Masuta, Y., Minaga, K., Kurimoto, M., Sekai, I., Hara, A., Omaru, N., Okai, N., Otsuka, Y., Takada, R., Yoshikawa, T., et al. (2022) · International Immunology · doi:10.1093/intimm/dxac045 · Cited by 27
Pagoldh, M., Hultgren, E., Arnell, P., & Eriksson, A. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.819443 · Cited by 27
Matsumura, T., Amiya, E., Tamura, N., Maejima, Y., Komuro, I., & Isobe, M. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0661-5 · Cited by 27
Dragašević, S., Stanković, B., Sokić-Milutinović, A., Milosavljević, T., Alempijevic, T. M., Lukić, S., Dražilov, S. S., Klaassen, K., Kotur, N., Pavlović, S., et al. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.09.001 · Cited by 27
Towards improved control of inflammatory bowel disease
Eberhardson, M., Hedin, C. R. H., Carlson, M., Tarnawski, L., Levine, Y. A., & Olofsson, P. S. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12745 · Cited by 28
Cdcs1 a major colitis susceptibility locus in mice; Subcongenic analysis reveals genetic complexity
Bleich, A., Büchler, G., Beckwith, J., Petell, L. M., Affourtit, J. P., King, B. L., Shaffer, D. J., Roopenian, D. C., Hedrich, H. J., Sundberg, J. P., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21146 · Cited by 27
Rahmi, G., Pidial, L., Silva, A. K. A., Blondiaux, E., Meresse, B., Gazeau, F., Autret, G., Balvay, D., Cuenod, C. A., Perretta, S., et al. (2016) · Theranostics · doi:10.7150/thno.14064 · Cited by 26
Vitamin D and the Immune System
Khorasanizadeh, M. H., Eskian, M., Camargo, C. A., & Rezaei, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-16073-9_2 · Cited by 26
Role of Smad7 in inflammatory bowel diseases
Monteleone, G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i40.5664 · Cited by 26
Wang, R. X., & Colgan, S. P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.02.002 · Cited by 29
Granström, A. L., Ludvigsson, J. F., & Wester, T. (2020) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2020.11.015 · Cited by 26
Yang, T., Cui, X. J., Tang, M., Qi, W., Zhu, Z., Shi, M., Yang, L., Pei, H., Zhang, W., Xie, L., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01137 · Cited by 26
CD4+ T Cells and Lactobacillus casei Control Relapsing Colitis Mediated by CD8+ T Cells
Hacini‐Rachinel, F., Nancey, S., Boschetti, G., Sardi, F., Doucet-Ladevèze, R., Durand, P.-Y., Flourié, B., & Kaiserlian, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804267 · Cited by 26
Jyonouchi, H., Geng, L., Cushing‐Ruby, A., & Monteiro, I. M. (2009) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2009.00923.x · Cited by 26
Gathungu, G. N., Zhang, C., Zhang, W., & Cho, J. H. (2012) · Genes and Immunity · doi:10.1038/gene.2011.90 · Cited by 26
Self-citationMitroulis, I., Kourtzelis, I., Kambas, K., Chrysanthopoulou, A., & Ritis, K. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.11.006 · Cited by 27
Petruo, V. A., Zeißig, S., Schmelz, R., Hampe, J., & Beste, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-14345-5 · Cited by 27
O’Donnell, S., Borowski, K., Espin‐Garcia, O., Milgrom, R., Kabakchiev, B., Stempak, J. M., Panikkath, D. R., Eksteen, B., Xu, W., Steinhart, A. H., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz016 · Cited by 26
Adeyanju, O., Okou, D. T., Huang, C. S., Kumar, A., Sauer, C. G., Galloway, C., Prasad, M., Waters, J. P., Cutler, D. J., Zwick, M. E., et al. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22944 · Cited by 26
Neural Control of Inflammation: Bioelectronic Medicine in Treatment of Chronic Inflammatory DiseasePreprint
Eberhardson, M., Tarnawski, L., Centa, M., & Olofsson, P. S. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034181 · Cited by 27
Lo, C., Khalili, H., Lochhead, P. J., Song, M., Lopes, E. W., Burke, K. E., Richter, J. M., Chan, A. T., & Ananthakrishnan, A. N. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16210 · Cited by 25
Finding a Place for Genomics in Health Disparities Research
Fullerton, S. M., Knerr, S. A., & Burke, W. (2012) · Public Health Genomics · doi:10.1159/000334717 · Cited by 26
Defective Apoptosis in Intestinal and Mesenteric Adipose Tissue of Crohn’s Disease Patients
Dias, C. B., Milanski, M., Portovedo, M., Horita, V. N., Ayrizono, M. D. L. S., Planell, N., Coy, C. S. R., Velloso, L. A., de Meirelles, L. R., & Leal, R. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098547 · Cited by 25
Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway
Aamodt, G., Bengtson, M., & Vatn, M. H. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-530 · Cited by 26
Banerjee, R., Balaji, M., Sasikala, M., Anuradha, S., Rao, G. V., & Reddy, D. N. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2667-0 · Cited by 25
Corticosteroid therapy in ulcerative colitis: Clinical response and predictors
Li, J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i10.3005 · Cited by 25
HLA-C*01 is a Risk Factor for Crohnʼs Disease
Jung, E. S., Cheon, J. H., Lee, J. H., Park, S. J., Jang, H. W., Chung, S. H., Park, M. H., Kim, T.-G., Oh, H., Yang, S., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000693 · Cited by 25
Using Zebrafish to Investigate Interactions Between Xenobiotics and Microbiota
Catron, T. R., Gaballah, S., & Tal, T. L. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00203-7 · Cited by 26
Jun-hao, X., Mao, C., Sha, X., Jin, Z., Wang, H., Liu, Y., & Ning, Y. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12981 · Cited by 24
Vijay–Kumar, M., & Gewirtz, A. T. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20734 · Cited by 24
Nutritional treatment in inflammatory bowel disease: An update
Guagnozzi, D., González-Castillo, S., Olveira, A., & Lucendo, A. J. (2012) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082012000900006 · Cited by 24
Mesenchymal stromal cells and chronic inflammatory bowel disease
Algeri, M., Conforti, A., Pitisci, A., Starc, N., Tomao, L., Bernardo, M. E., & Locatelli, F. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.06.018 · Cited by 24
Guo, Z., Gong, J., Li, Y., Gu, L., Cao, L., Wang, Z., Zhu, W., & Li, J. (2016) · Nutrients · doi:10.3390/nu8080519 · Cited by 24
Liang, J., van Abbema, A., Balázs, M., Barrett, K., Berezhkovsky, L., Blair, W. S., Chang, C. C., Delarosa, D., DeVoss, J., Driscoll, J., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.022 · Cited by 24
Masaki, S., Masuta, Y., Honjo, H., Kudo, M., & Watanabe, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433620 · Cited by 24
Simčič, S., Berlec, A., Stopinšek, S., Štrukelj, B., & Orel, R. (2019) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-019-2615-z · Cited by 23
Mesenchymal Stem Cells and Tuberculosis: Clinical Challenges and Opportunities
Zhang, X., Xie, Q., Ye, Z., Li, Y., Che, Z., Huang, M., & Zeng, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695278 · Cited by 24
Toward a better understanding of the central consequences of intestinal inflammation
Nyuyki, K. D., & Pittman, Q. J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12935 · Cited by 26
Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis
Chen, Z., Yu, K., Zhu, F., & Gorczynski, R. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146681 · Cited by 23
Thymol has beneficial effects on the experimental model of ulcerative colitis.
Tahmasebi, P., Froushani, S. M. A., & Ahangaran, N. A. (2019) · Europe PMC (PubMed Central) · doi:10.22038/ajp.2019.13383 · Cited by 23
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis
Becker, W., Alrafas, H. R., Busbee, P. B., Walla, M. D., Wilson, K. M., Miranda, K., Cai, G., Putluri, V., Putluri, N., Nagarkatti, M., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa253 · Cited by 23
Chen, J., Xie, L., Toyama, S., Hünig, T., Takahara, S., Li, X., & Zhong, L. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.034 · Cited by 23
Characterization of an Interferon-stimulated Response Element (ISRE) in the Il23a Promoter
Sheikh, S. Z., Kobayashi, T., Matsuoka, K., Onyiah, J. C., & Plevy, S. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.147884 · Cited by 22
Perez, L. H., Butler, M., Creasey, T., Dzink-Fox, J., Gounarides, J., Petit, S., Ropenga, A., Ryder, N. S., Smith, K., SMITH, P. F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010915 · Cited by 22
Yu, W., Lin, Z., Pastor, D. M., Hegarty, J. P., Chen, X., Kelly, A. A., Wang, Y., Poritz, L. S., & Koltun, W. A. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1138-0 · Cited by 22
Martins, A. J., Colquhoun, P. H. D., Reid, G., & Kim, S. O. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20808 · Cited by 22
Buongusto, F., Bernardazzi, C., Yoshimoto, A. N., Nanini, H. F., Coutinho, R. L. M., Carneiro, A. J., Castelo-Branco, M. T. L., & de Souza, H. S. P. (2016) · Clinical and Experimental Medicine · doi:10.1007/s10238-016-0434-1 · Cited by 22
Metadata
- Authors
- Cho, J. H.
- Affiliations
- Yale University (US)
- Corresponding author
- Cho, Judy H.
- ORCID
- Cho, Judy H.
- Venue
- Nature Reviews Immunology
- Published
- 2008-06
- Volume
- 8
- Issue
- 6
- Pages
- 458-466
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2066203385
- Cited by
- 940
- References
- 99
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 28 · 2023: 30 · 2022: 30 · 2021: 32 · 2020: 47 · 2019: 39 · 2018: 45 · 2017: 37 · 2016: 53 · 2015: 50 · 2014: 61 · 2013: 71 · 2012: 80
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Georgia Clinical and Translational Science Alliance
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK62429, U01DK62422, R01DK072373, U01DK062429, U01DK062422)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, genetic susceptibility, immunopathogenesis, NOD2, ATG16L1, autophagy, IL23R, IL12B, STAT3, NKX2-3, bacterial sensing, cytokine signaling, innate immunity, adaptive immunity, genome-wide association study
- MeSH terms
- Animals, Colitis, Ulcerative, Crohn Disease, Humans, Inflammatory Bowel Diseases, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review